Publication | Open Access

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial

VaccinationVaccine SafetyVaccinologyPhase 1/2Vaccine DevelopmentPediatricsVaccine EfficacyInactivated Sars-cov-2 VaccineMedicineHealthy ChildrenCovid-19